A female with central anticholinergic syndrome responsive to neostigmine

Pediatric Neurology

Volumn 23, Issue 2, 2000, Pages 185-187

  Parisi, Pasquale ^a   Francia, Ada ^b  

^a Dept Pediat Outpatient Serv C   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMMONIA; NEOSTIGMINE METHYL SULFATE; PHYSOSTIGMINE SALICYLATE; SOLANUM ALKALOID;

ANTICHOLINERGIC EFFECT; ARTICLE; BLOOD BRAIN BARRIER; CASE REPORT; CHILD; DIFFERENTIAL DIAGNOSIS; DRUG PENETRATION; FEMALE; HUMAN; INTOXICATION; PLANT; PRIORITY JOURNAL;

ATAXIA; BLOOD-BRAIN BARRIER; CASE REPORT; CHILD, PRESCHOOL; CHOLINESTERASE INHIBITORS; FEMALE; HALLUCINATIONS; HUMAN; NEOSTIGMINE; SEIZURES; SOLANACEOUS ALKALOIDS; SYNDROME;

EID: 0033804632     PISSN: 08878994     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0887-8994(00)00165-X     Document Type: Article

References (6)

1. Longo V.G. Behavioral and electroencephalographic effects of atropine and related compounds. Pharmacol Rev. 18:1966;965-966.
2. Speich R., Haller A. Central anticholinergic syndrome with the antimalarial drug mefloquine. N Engl J Med. 331:1994;57-58.
3. Watemberg N.M., Roth K.S., Alehan F.K., Epstein C.E. Central anticholinergic syndrome on therapeutic dose of cyproheptadine. Pediatrics. 103:1999;158-160.
4. Ceha L.J., Presperin C., Young E., Allswede M., Erickson T. Anticholinergic toxicity from night-shade berry poisoning responsive to physostigmine. J Emerg Med. 15:1997;65-69.
5. Perrone J., Chu J., Stecker M.M. Viral encephalitis masquerading as a fulminant anticholinergic toxidrome. J Toxicol Clin Toxicol. 35:1997;627-633.
6. Friedman A., Kaufer D., Shemer J., Hendler I., Soreq H., Tur-Kaspa I. Pyridostigmine brain penetration under stress enhances neuronal excitability and induces early immediate transcriptional response. Nat Med. 2:1996;1382-1385.